Terms & Conditions – InSilens, Biotech Intelligence

Last Updated: July 11, 2026

These Terms and Conditions govern your access to and use of www.insilens.com, the InSilens website, platform, newsletters, reports, dashboards, databases, alerts, briefings, downloadable materials, subscription services, software features, and related products or services.

InSilens is a product, website, platform, and service owned and operated by Noetera, Inc., a Delaware corporation. InSilens is the trade name and product brand through which Noetera, Inc. provides biotechnology, pharmaceutical, healthcare, life sciences, market intelligence, and related information services.

For purposes of these Terms, “InSilens,” “Noetera,” “Company,” “we,” “us,” or “our” means Noetera, Inc., operating through the InSilens platform, and where applicable its affiliates, contractors, vendors, service providers, licensors, successors, and assigns. “User,” “you,” or “your” means any individual, company, organization, institution, investor, subscriber, visitor, or other person accessing or using the Services.

By visiting, browsing, registering for, subscribing to, purchasing, accessing, downloading, or using any part of the Services, you agree to be bound by these Terms. If you use the Services on behalf of a company, fund, institution, employer, or other organization, you represent that you have authority to bind that organization, and that organization will be responsible for your use of the Services.

If you do not agree to these Terms, you must not use the Services.

1. The Services

InSilens provides biotechnology, pharmaceutical, healthcare, life sciences, clinical, regulatory, scientific, business development, financing, transaction, company, asset, indication, modality, and market intelligence content.

The Services may include, without limitation:

biotech and pharmaceutical news analysis;
market intelligence briefings;
clinical, regulatory, financing, and transaction summaries;
company, asset, therapeutic-area, and modality profiles;
newsletters, email alerts, and periodic reports;
dashboards, datasets, tables, rankings, and scoring tools;
downloadable reports, spreadsheets, images, and visual materials;
AI-assisted summaries, classifications, signal analysis, or data enrichment;
custom intelligence products or research services, if separately agreed in writing.

We may add, modify, suspend, restrict, replace, or discontinue any part of the Services at any time, subject to any separate written agreement that may apply to paid enterprise or subscription access.

2. Other Applicable Policies and Agreements

These Terms apply together with any other policies, notices, or agreements that govern your use of the Services, including our Privacy Policy, Cookie Policy, subscription terms, order forms, invoices, statements of work, enterprise agreements, data-processing agreements, or product-specific notices.

If a separate written agreement signed or accepted by both you and Noetera, Inc. conflicts with these Terms, the separate written agreement will control only for the specific subject matter of the conflict.

3. Eligibility and Permitted Use

The Services are intended for professional, commercial, research, investment-analysis, business-development, strategic, and informational use.

You may not use the Services if:

you are under 18 years old, or the age of majority in your jurisdiction if higher;
you are legally prohibited from using the Services;
your access has previously been suspended or terminated by us;
your use would violate applicable law, sanctions restrictions, export-control rules, securities laws, healthcare laws, privacy laws, or intellectual property laws.

You are responsible for ensuring that all users who access the Services through your account, organization, subscription, network, or credentials comply with these Terms.

4. Accounts and Security

Some features may require an account, login credentials, subscription approval, or registration. You agree to provide accurate, current, and complete information when creating or maintaining an account, and to keep usernames, passwords, access links, API keys, and other credentials confidential.

You are responsible for all activity that occurs through your account, whether or not authorized by you, and must promptly notify us if you suspect unauthorized access, credential sharing, account misuse, or a security issue.

You may not:

share login credentials with unauthorized users, or allow access outside the scope of your subscription;
use another person’s or organization’s account without permission;
create false, misleading, or duplicate accounts;
bypass authentication, paywalls, access controls, or usage restrictions.

We may suspend or terminate access if we believe an account has been misused, compromised, shared improperly, or used in violation of these Terms.

5. Subscriptions, Trials, Fees, and Payments

Certain Services may be offered through paid subscriptions, enterprise plans, free trials, beta access, pilot programs, promotional access, or custom agreements. If you purchase paid Services, you agree to pay all applicable fees, taxes, and charges according to the applicable subscription page, invoice, order form, or written agreement.

Unless otherwise stated in writing:

fees are payable in U.S. dollars and due according to the billing terms presented at purchase or in the applicable agreement;
subscriptions may renew automatically if stated in the applicable plan or order form;
failure to pay may result in suspension or termination of access;
fees are non-refundable except where required by law or expressly agreed in writing;
you are responsible for taxes, duties, and governmental charges associated with your purchase, except taxes based on our net income.

Trial, beta, pilot, preview, free, or promotional access may be modified, limited, suspended, or discontinued at any time.

6. Informational Use Only; No Professional Advice

The Services are provided for informational, educational, research, strategic, and general business-intelligence purposes only. The Services do not provide, and should not be interpreted as providing, investment, securities, trading, personalized financial, medical, diagnostic, treatment, patient-care, legal, regulatory, tax, accounting, or business advice tailored to your specific circumstances.

Nothing in the Services is an offer, solicitation, recommendation, endorsement, or instruction to buy, sell, hold, trade, prescribe, use, license, acquire, divest, finance, develop, commercialize, or invest in any security, company, therapy, drug candidate, biological product, medical device, technology, asset, intellectual property, or business opportunity.

You are solely responsible for your own decisions and should consult qualified professional advisors before making investment, clinical, regulatory, legal, tax, accounting, financing, licensing, acquisition, divestiture, or strategic decisions.

7. No Medical, Clinical, or Patient-Specific Reliance

The Services may discuss diseases, drug candidates, mechanisms of action, genetic targets, clinical trials, biomarkers, regulatory actions, approved products, investigational therapies, scientific publications, and healthcare markets. This information is not medical advice and must not be used to diagnose, treat, prevent, monitor, or manage any disease or health condition. The Services are not designed or intended to function as a medical device, clinical decision-support tool, prescribing system, or substitute for professional medical judgment.

Users must verify clinical, scientific, and regulatory information through official sources, including regulatory agencies, clinical trial registries, product labels, company disclosures, peer-reviewed publications, and qualified healthcare professionals.

8. No Investment, Trading, or Securities Reliance

The Services may include information or commentary about public and private companies, financings, stock market reactions, mergers and acquisitions, licensing transactions, clinical catalysts, regulatory events, competitive positioning, investor sentiment, valuations, or market opportunities. Such content is not investment advice and is not intended to recommend any securities transaction.

Biotech and healthcare investments involve substantial risk, including clinical failure, regulatory rejection, commercialization challenges, financing risk, dilution, competition, market volatility, and potential loss of capital. You acknowledge that any trading, investment, financing, licensing, acquisition, divestiture, or business decision you make is made independently and at your own risk.

9. AI-Assisted Content and Data Processing

Some Services may use artificial intelligence, machine learning, natural language processing, automated extraction, data enrichment, algorithmic classification, or other computational methods to organize, summarize, classify, score, or analyze information.

AI-assisted or algorithmic outputs may be incomplete, inaccurate, outdated, misclassified, biased, or based on limited source material. We may use human, editorial, source, and quality-control review, but we do not guarantee that any AI-assisted or algorithmic output is error-free, complete, current, unbiased, or suitable for your specific purpose. You are responsible for independently verifying all information before relying on it.

10. Sources, Third-Party Information, and Links

The Services may reference, summarize, cite, link to, or analyze information from third-party sources, including company press releases, regulatory databases, securities filings, clinical trial registries, scientific publications, investor materials, conference presentations, news outlets, industry databases, and public websites. Third-party materials remain the property of their respective owners, and references to them do not imply endorsement, sponsorship, affiliation, approval, or verification.

The Services may also link to third-party websites, platforms, resources, products, or services. We do not control and are not responsible for their content, accuracy, availability, security, privacy practices, terms, products, services, or performance. Your use of third-party websites or services is at your own risk.

11. Accuracy, Completeness, and Timeliness

We aim to provide high-quality intelligence, but the Services may contain errors, omissions, delays, outdated information, incomplete data, interpretation errors, classification errors, source errors, or typographical mistakes. We do not guarantee that any content, analysis, signal, score, ranking, category, or interpretation is accurate, complete, current, or reliable, that any company, trial, product, regulatory, transaction, or market information remains up to date, that errors will be corrected, or that content will remain available.

Users should verify important information through primary sources and qualified professional advisors.

12. Ownership and Intellectual Property

The Services and all related content, databases, reports, designs, text, graphics, logos, interfaces, dashboards, visualizations, software, code, data structures, taxonomies, categories, scoring methods, workflows, compilations, summaries, analyses, and other materials are owned by or licensed to Noetera, Inc. and are protected by intellectual property, database, trade secret, copyright, trademark, and contract laws.

Except as expressly allowed by these Terms or a separate written agreement, you receive no ownership rights in the Services or any content made available through them. All rights not expressly granted are reserved by Noetera, Inc.

You may not use the InSilens name, Noetera name, logos, trademarks, trade names, service marks, branding, or confusingly similar marks without our prior written permission.

13. Limited License

Subject to your compliance with these Terms and any applicable subscription terms, Noetera, Inc. grants you a limited, revocable, non-exclusive, non-transferable, non-sublicensable right to access and use the Services for internal informational, research, evaluation, and business-intelligence purposes.

Unless separately authorized in writing, you may not:

copy, reproduce, publish, sell, license, distribute, or commercialize the Services;
modify, translate, adapt, or create derivative works from the Services;
share paid or restricted content with unauthorized users;
use the Services to build, train, enrich, validate, benchmark, or improve a competing product, database, model, or service;
remove proprietary notices, source references, or attribution;
reverse engineer, decompile, disassemble, or attempt to discover non-public systems, code, prompts, workflows, methods, or data pipelines;
use the Services outside the scope of your subscription or permitted access.

14. Internal Sharing and Limited Excerpts

Unless a separate written agreement allows broader use, you may share limited, non-substantial excerpts from the Services internally within your organization for ordinary-course business discussion, research, or analysis. Any internal excerpt must be limited in scope, identify InSilens as the source where reasonable, and not substitute for a subscription.

Excerpts may not be externally distributed, sold, licensed, published, or made publicly available; used to build a competing product, model, platform, or dataset; or stripped of proprietary notices, source references, or attribution.

You may not systematically download, archive, export, reproduce, or redistribute substantial portions of the Services without our prior written permission.

15. Restrictions on Scraping, Data Extraction, and AI Training

You may not access or use the Services through bots, crawlers, scrapers, spiders, browser automation, scripts, data-mining tools, extraction tools, or similar automated or manual processes designed to collect content at scale.

You may not use the Services or any content from the Services to train, fine-tune, test, benchmark, validate, prompt, enrich, or improve any artificial intelligence system, machine learning model, large language model, search engine, analytics product, database, or competing intelligence service without our prior written permission.

You may not bypass paywalls, access controls, rate limits, authentication systems, technical safeguards, or robot-exclusion protocols. Unauthorized scraping, extraction, automated access, AI training, redistribution, or competitive use is a material breach of these Terms.

16. Prohibited Conduct

You agree not to use the Services to:

violate any law or regulation, or infringe intellectual property, privacy, publicity, contractual, confidentiality, or other rights;
mislead, defraud, impersonate, harass, threaten, or harm another person or entity;
upload or transmit malware, viruses, harmful code, or disruptive files;
interfere with the security, availability, or operation of the Services;
gain unauthorized access to accounts, systems, data, or networks, or probe, scan, or test vulnerabilities without written authorization;
harvest personal information or send spam or unauthorized communications;
misrepresent your identity, credentials, or affiliation;
bypass subscription limits or access restrictions;
assist any third party in doing anything prohibited by these Terms.

17. User Submissions and Feedback

You may provide comments, questions, feedback, suggestions, corrections, contact information, business information, support requests, or other materials through the Services. You represent that anything you submit is accurate to the best of your knowledge, does not violate law or third-party rights, does not contain confidential information you are not authorized to disclose or harmful code, and may be used by us as described in these Terms and our Privacy Policy.

If you send us feedback, ideas, suggestions, improvements, corrections, or recommendations, you grant Noetera, Inc. a worldwide, perpetual, irrevocable, royalty-free, sublicensable, transferable right to use, reproduce, modify, commercialize, and otherwise exploit that feedback without restriction, payment, or obligation to you.

Do not submit confidential, sensitive, regulated, or proprietary information unless necessary and authorized.

18. Interactive Features

If the Services include comments, community features, uploads, discussion tools, user profiles, or other interactive areas, you are responsible for the content you submit. You may not submit content that is unlawful, false, misleading, defamatory, obscene, abusive, discriminatory, threatening, infringing, invasive of privacy, confidential, spam-like, malicious, or otherwise harmful.

We may remove, edit, restrict, or refuse user-submitted content at any time. We are not required to monitor all user submissions.

19. Privacy, Cookies, and Communications

Our handling of personal information is described in our Privacy Policy, and our use of cookies and similar technologies is described in our Cookie Policy. By using the Services, you acknowledge that personal information may be collected and processed according to those policies, and you are responsible for ensuring that any personal information you provide is accurate and that you have authority to provide it.

If you subscribe to newsletters, alerts, updates, or other communications, we may send you emails about InSilens content, products, services, account activity, legal notices, billing, security, or platform updates. You may opt out of non-essential marketing communications using the unsubscribe mechanism provided or by contacting us. We may still send transactional, administrative, legal, billing, security, or service-related communications where permitted by law.

20. Availability, Security, and Beta Features

We may work to maintain reliable access to the Services, but we do not guarantee that the Services will be uninterrupted, secure, error-free, virus-free, or continuously available. The Services may be affected by maintenance, updates, outages, cyber incidents, cloud-provider failures, third-party service interruptions, internet disruptions, technical problems, or events beyond our control.

You are responsible for maintaining your own internet connection, devices, browsers, software, cybersecurity protections, and access systems. We may offer beta, preview, trial, pilot, or experimental features that may be incomplete, unstable, inaccurate, unavailable, or changed without notice. You use them at your own risk.

21. Corrections and Removal Requests

If you believe that content on the Services is inaccurate, outdated, improperly attributed, infringing, or should be removed, you may contact us. Please include your name and contact information, the URL or location of the content, a clear explanation of the issue, supporting evidence, and, if applicable, proof that you own or represent the relevant rights.

We may review and respond to such requests in our discretion or as required by law. Submission of a request does not guarantee correction, removal, or response.

22. Copyright Complaints

We respect intellectual property rights. If you believe content on the Services infringes your copyright, please send a notice containing:

your physical or electronic signature;
identification of the copyrighted work;
identification of the allegedly infringing material and where it appears;
your name, address, telephone number, and email address;
a statement that you have a good-faith belief the use is not authorized by the copyright owner, its agent, or the law;
a statement that the information in your notice is accurate and that you are the copyright owner or authorized to act for the owner.

Upon receipt of a valid notice, we will remove or disable access to the identified material as appropriate and, in accordance with our repeat-infringer policy, will terminate the accounts of users determined to be repeat infringers in appropriate circumstances.

Noetera, Inc. / InSilens

Attn: Copyright Agent

Website: www.insilens.com

Email: info@noetera.com

23. Confidential and Non-Public Materials

If you receive access to private reports, beta features, confidential demos, non-public product roadmaps, unpublished analyses, enterprise materials, custom research, pricing information, or other non-public materials, you may not disclose those materials to third parties without our prior written permission.

This does not restrict information that becomes public through no fault of yours, was lawfully known to you before disclosure, or must be disclosed by law.

24. Disclaimers

To the maximum extent permitted by law, the Services are provided on an “as available” and “as presented” basis. Noetera, Inc. disclaims all warranties and representations of any kind, whether express, implied, statutory, or otherwise, including warranties of accuracy, completeness, timeliness, reliability, merchantability, fitness for a particular purpose, title, non-infringement, security, uninterrupted access, and error-free operation.

We do not guarantee that the Services will meet your expectations or that any result, conclusion, signal, analysis, ranking, classification, or score will be correct or useful for your specific purpose. We do not warrant that defects will be corrected or that the Services, content, servers, emails, downloads, or links are free from viruses, malware, or harmful components.

25. Limitation of Liability

To the maximum extent permitted by law, Noetera, Inc., InSilens, and their officers, directors, employees, contractors, affiliates, licensors, service providers, agents, successors, and assigns will not be liable for indirect, incidental, consequential, special, exemplary, punitive, or enhanced damages, including lost profits, lost revenue, lost data, lost opportunities, business interruption, reputational harm, investment losses, trading losses, loss of goodwill, or loss of anticipated savings.

This limitation applies to claims arising from or relating to:

use of or inability to use the Services;
reliance on any content, data, signal, score, alert, or analysis;
investment, trading, clinical, regulatory, legal, tax, licensing, financing, acquisition, divestiture, or business decisions;
errors, omissions, delays, inaccuracies, or interruptions;
third-party websites, services, or information;
unauthorized access to your account;
malware, cyberattacks, or harmful code;
suspension, modification, or termination of access.

To the maximum extent permitted by law, our total aggregate liability for all claims relating to the Services or these Terms will not exceed the greater of (a) one hundred U.S. dollars, or (b) the amount you paid to Noetera, Inc. for the specific paid service giving rise to the claim during the six months before the event giving rise to the claim.

Some jurisdictions do not allow certain exclusions or limitations. In those jurisdictions, liability will be limited to the greatest extent permitted by law.

26. Indemnification

You agree to defend, indemnify, and hold harmless Noetera, Inc., InSilens, and their officers, directors, employees, contractors, affiliates, licensors, service providers, agents, successors, and assigns from and against any claims, damages, losses, liabilities, costs, and expenses, including reasonable attorneys’ fees, arising from or related to:

your use of the Services;
your violation of these Terms or of law;
your infringement or alleged infringement of third-party rights;
content or information you submit;
activity occurring through your account;
unauthorized sharing, scraping, extraction, redistribution, AI training, or competitive use of the Services.

We may assume control of the defense of any matter subject to indemnification, and you agree to cooperate with our defense.

27. Suspension and Termination

We may suspend, restrict, or terminate your access to the Services at any time if we believe that you violated these Terms, your account was misused or compromised, your use creates legal, commercial, operational, reputational, or security risk, payment is overdue, or continuing access could harm Noetera, Inc., InSilens, other users, third parties, or the Services.

Upon termination, your right to access the Services ends immediately. We may disable your account, restrict access, or delete information according to applicable law and our internal policies.

Provisions that by their nature should survive termination will survive, including provisions relating to intellectual property, usage restrictions, confidentiality, disclaimers, liability limits, indemnification, governing law, and dispute resolution.

28. Changes to These Terms or the Services

We may update these Terms from time to time. The updated version will be indicated by a revised “Last Updated” date. If changes are material, we may provide notice by posting on the website, sending an email, displaying an in-product notice, or using another reasonable method.

Your continued use of the Services after updated Terms become effective means you accept the revised Terms. If you do not accept the revised Terms, you must stop using the Services.

We may also modify, update, remove, suspend, discontinue, rebrand, replace, or restrict any part of the Services at any time. We are not liable for any modification, suspension, or discontinuation except as expressly stated in a separate written agreement.

29. International Use, Export Controls, and Sanctions

The Services are operated from the United States. We do not represent that the Services are appropriate or available in every jurisdiction. You are responsible for complying with all applicable laws, including export-control laws, sanctions laws, privacy laws, securities laws, healthcare laws, and intellectual property laws.

You may not use, export, re-export, transfer, or make available the Services in violation of applicable law, including to any person, entity, or jurisdiction subject to U.S. sanctions or export restrictions.

30. Force Majeure

We are not responsible for delay or failure to perform caused by events beyond our reasonable control, including natural disasters, war, terrorism, labor disputes, public health emergencies, government action, internet failures, power failures, cloud-service outages, cyberattacks, supply-chain disruptions, or other events outside our reasonable control.

31. Governing Law and Venue

These Terms and any dispute arising from or relating to the Services will be governed by the laws of the State of Delaware, without regard to conflict-of-law principles.

Subject to Section 32 (Arbitration; Class Action Waiver) and any mandatory applicable law or separate written agreement, you and Noetera, Inc. agree that the state and federal courts located in Delaware will have exclusive jurisdiction over disputes arising from or relating to these Terms or the Services. You consent to personal jurisdiction and venue in those courts.

32. Arbitration; Class Action Waiver; Jury Trial Waiver

Except for disputes that qualify for small claims court, disputes involving actual or threatened infringement or misappropriation of intellectual property, or claims for injunctive relief to enforce Sections 12–15 (Ownership, Limited License, Internal Sharing, and Scraping/AI Training restrictions), you and Noetera, Inc. agree that any dispute arising from or relating to these Terms or the Services will be resolved by binding arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules, rather than in court.

The arbitration will be conducted on an individual basis. You and Noetera, Inc. each waive the right to a jury trial and the right to participate in a class action, class arbitration, or representative proceeding. The arbitrator may not consolidate more than one person’s claims and may not preside over any form of a representative or class proceeding.

You may opt out of this arbitration agreement by sending written notice to info@noetera.com within 30 days of first accepting these Terms; if you opt out, disputes will proceed under Section 31 (Governing Law and Venue) instead. If any part of this Section is found unenforceable, the remainder will still apply, except that if the class-action waiver is found unenforceable as to a particular claim, that claim (and only that claim) will proceed in the courts identified in Section 31.

33. Miscellaneous

If any part of these Terms is found invalid, unlawful, or unenforceable, that part will be modified or removed only to the minimum extent necessary. The remaining provisions will remain in effect.

Our failure to enforce any provision of these Terms does not waive our right to enforce that provision or any other provision later.

You may not assign or transfer your rights or obligations under these Terms without our prior written consent. We may assign or transfer these Terms in connection with a merger, acquisition, financing, corporate restructuring, sale of assets, change of control, or transfer of the Services.

These Terms, together with any applicable Privacy Policy, Cookie Policy, order form, subscription terms, product notice, or written agreement, form the entire agreement between you and Noetera, Inc. regarding the Services and replace any prior or contemporaneous understandings about the same subject matter.

34. Contact Information

For questions about these Terms, permissions, copyright issues, correction requests, subscriptions, account access, or legal matters, please contact:

Noetera, Inc.

Operator of the InSilens platform